期刊
NEUROBIOLOGY OF AGING
卷 61, 期 -, 页码 132-137出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.neurobiolaging.2017.09.023
关键词
Amyotrophic lateral sclerosis; ALS; Fecal microbiota; Gut microbiota; Microbiome; 16S rRNA gene sequencing
资金
- German Federal Ministry of Education and Research (JPND STRENGTH consortium
- German network for ALS research MNDNET) [BMBF 01ED1408]
- Charcot Foundation
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative motor neuron disease accompanied by both systemic and central nervous system-specific inflammation as well as deregulated energy metabolism. These potential pathogenetic factors have recently been found to mutually interact with the gut microbiota, raising the hypothesis of a link between microbiome alterations and ALS pathogenesis. The aim of our study was to assess whether ALS is associated with an altered composition of the fecal microbiota. We compared the fecal microbiota of 25 ALS patients with 32 age-and gender-matched healthy persons using 16S rRNA gene sequencing analysis. Confounding factors and secondary disease effects on the microbiome were minimized by selection of patients without dysphagia, gastrostomy, noninvasive ventilation, or reduced body mass index. Comparing the 2 carefully matched groups, the diversity and the abundance of the bacterial taxa on the different taxonomic levels as well as PICRUSt-predicted metagenomes were almost indistinguishable. Significant differences between ALS patients and healthy controls were only observed with regard to the overall number of microbial species (operational taxonomic units) and in the abundance of uncultured Rumino-coccaceae. Conclusively, ALS patients do not exhibit a substantial alteration of the gut microbiota composition. (C) 2017 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据